Jong Sung Park

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 2.8K citations · Full text

Metabolic Syndrome, Diabetes Management, Cardiovascular Disease +9

Involvement of Toll-like Receptors 2 and 4 in Cellular Activation by High Mobility Group Box 1 Protein

Jong Sung Park, Daiva Svetkauskaite, Qianbin He et al. · Journal of Biological Chemistry · 2004 · 1.5K citations · Full text

Block of A1 astrocyte conversion by microglia is neuroprotective in models of Parkinson’s disease

Seung Pil Yun, Tae‐In Kam, Nikhil Panicker et al. · Nature Medicine · 2018 · 1.1K citations · Full text

Neurodegenerative Diseases, Medicine, A1 Astrocyte Conversion +9

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 600 citations · Full text

Metabolic Syndrome, Diabetes Management, Urology +10

Activation of gene expression in human neutrophils by high mobility group box 1 protein

Jong Sung Park, John J. Arcaroli, Ho-Kee Yum et al. · American Journal of Physiology-Cell Physiology · 2003 · 430 citations

Acute Lung Injury, Inflammatory Lung Disease, Lung Inflammation +22